Video

Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations

Author(s):

Rodney Rohde, SV, SM, MB (ASCP), FACSc,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
Washington, DC, USA - June 24, 2022: The symbol of the U.S. Department of Health and Human Services is seen at the entrance to its headquarters in the Hubert H. Humphrey Building in Washington, DC
May 30th 2025

HHS Cancels Millions in Pandemic Influenza mRNA Vaccine Development Grants

Luke Halpern, Assistant Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Xofluza (Baloxavir Marboxil ) oral capsule -- Image credit: Joel bubble ben | stock.adobe.com
May 3rd 2025

Single Dose of Xofluza Reduces Odds of Untreated Household Members Contracting Influenza

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Marcella Kinaya, PharmD, pharmacist and licensed district leader with CVS Health.
March 25th 2025

Marcella Kinaya, PharmD, on Flu Season: ‘We’re Here to Protect People and Make Sure They’re Healthy’

Gillian McGovern, Associate Editor Marcella Kinaya, PharmD
Health care worker filling syringe from flu vaccine vial | Image Credit: © Aron M - Austria - stock.adobe.com
March 3rd 2025

FDA Annual Flu Vaccine Meeting and CDC’s ‘Wild to Mild’ Campaign Canceled

Alexandra Gerlach, Associate Editor